Samantha Armstrong

We did a new topic this week! Rad Onc 101 with @RadOncTalks ☢️ In part 1, we reviewed types of RT, how it works, the patient experience & common AEs In part 2 we will review duration & fractionation schemes, indications for RT & more @HemOncFellows

CONGRATS to all of those who matched into the best speciality this past week!! & congrats to all who found out they passed their Onc Boards today, we love hearing from you ❤️ We are back this week with updates on GISTs & next week from #ASH25 podcasts.apple.com/us/podcast/two…

Thank you @TwoOncDocs for the amazing podcast — learning so much from every episode! #oncolo

#desmoid has a sustained impact on pts lives ‼️at 10yr of disease only half remain at full time job ‼️ ONLY 17% received counseling by reproductive specialists ‼️Desmoid pts are often excluded from supportive programs reserved for cancer survivors #ctos25

When I started in #sarcoma, Brian welcomed me into the community. He once told me, when I become senior, to extend that same generosity & support to the next physician who joined our field. That was Brian, always lifting others up & inspiring us all to advance sarcoma together.

Checked in at #CTOS25 🌴🎗️

Congrats to all fellows who took boards last week! This week we covered some updates from #ESMO25 in urothelial CA: -#POTOMAC in NMIBC -#KN905 & #IMvigor011 in MIBC -#FORAGER1 & DV + Toripalamab in muC Coming up, will update Anal CA, Hodgkin Lymphoma topics & job search tips!

This week we released 2025 updates on soft tissue #sarcoma with our local sarcoma expert @SamArmstrongMD Which of the following is a preferred approved treatment since 2023 for unresectable desmoid tumors? @HemOncFellows

PFS benefit with anlotinib+doxo and anlotinib maintenance. Lower than expected ORR in doxo arm and almost impossible to believe equivalence in toxicity between the arms. Same question as doxo+trabectedin: what if sequential single agent were used? #ASCO25

#ATOMIC phase 3 trial: stage 3 CRC adjuvant Atezolizumab + FOLFOX vs FOLFOX For fellows ➡️where it fits in to current practice All pts need MMR testing! 10-15% localized CRC are dMMR 🌟 new SOC 10% improvement in 3yr DFS but also good results for neoadj IO #NICHE2 #ASCO25

Our wonderful @TheFellowOnCall colleague Dr. Vivek Patel presenting final results from our multicenter randomized PODCAST-HOF trial And hot off the press today, publication in JCO: ascopubs.org/doi/pdfdirect/… #ASCO25

Honored to be invited for the @OncMedEdCoP Keynote this AM w/ @OncBrothers! We discussed why, how, balance, topics, branding, research (podcast curriculum with @TheFellowOnCall to be presented at 1:15PM today), promotion, the changing landscape of med ed & digital ed #ASCO25

Honored to have been a keynote speaker this morning as half of @TwoOncDocs with @DrKarineTawagi along side @OncBrothers #asco2025 #MedEd

🤩 @TwoOncDocs @OncBrothers Happening NOW in S103 ‼️

Thank you all who joined Clinicals to Exams & guest appearance w/ baby Cary A few high-yield mnemonics: 🌟 ribociclib - “ribs” close to ❤️- Qtc; abemaciclib - “abs” - diarrhea 🌟 tumor marker half-life: Hcg -3 letters, 1-3d; AFP -alpha - 5 letters 5-7d Ready for #ASCO25 day 1!

Oncology Board Prep (#ClinicalsToExam) today with @TwoOncDocs! Then starting tomorrow, let’s take a dive into all the data coming at us from #ASCO25! #OncTwitter #MedTwitter

We are just 1 day away from our Clinicals to Exam board prep co-hosted with @OncBrothers We will cover high yield tips on: 🌟 board prep 101 🌟 breast CA 🌟 NSCLC 🌟 CRC 🌟 testicular CA 🌟 prostate CA Looking forward to seeing you all in Chicago tomorrow to kick off #ASCO25

🚨Calling all @asco #ASCO25 annual meeting attendees! Come join us in person for our annual #MedEd CoP event!! 🔔 Saturday May 31st 🔔 7:30-9:30 am 🔔 Room S103 ‼️Keynote speakers: @TwoOncDocs and @OncBrothers!! Can’t wait to see you there!! 🥰

Can’t wait to hear from @TwoOncDocs and @OncBrothers during this great session!! @SamArmstrongMD @DrKarineTawagi @RManochakian @Kathy_WalshMD @s_brond @IUCancerCenter @IUMedSchool @IUHemOnc

You know #ASCO25 is < 3 months away! It’s never too early to start planning, especially if you are going to be taking your boards! Onc Board Review, w/ @TwoOncDocs + @OncBrothers: 📅 May 29: theWit Chicago ✅ Register: bit.ly/boards2025 #OncTwitter @SignifyMD